Funko Inc. (NASDAQ: FNKO): Earnings are catching up while the stock bottoms, says Zacks, which named it as the Bull of the Day stock. The shares most recently closed at $16.25 and have a consensus price target of $24.89.
Goldman Sachs Group Inc. (NYSE: GS): Morgan Stanley upgraded the Wall Street powerhouse to Equal Weight from Underweight and has a $479 price target. The consensus target is $453.84. The last trade for Monday was reported at $389.30.
Hibbett Inc. (NASDAQ: HIBB): Baird upgraded the stock to Outperform from Neutral and has a $100 target price. The consensus target is $114.17. The last trade for Monday hit the tape at $73.59, which was up almost 7% for the day.
Insmed Inc. (NASDAQ: INSM): JPMorgan started coverage with an Overweight rating and a $45 target price. The consensus target is $53.44. The stock closed on Monday at $26.81.
Juniper Networks Inc. (NYSE: JNPR): Jefferies upgraded the shares to Buy from Hold and boosted the $28 price target to $42. The consensus target is $28.50. The stock closed on Monday at $31.45. The shares were up close to 4% in premarket trading.
Lennox International Inc. (NYSE: LII): Deutsche Bank raised its Hold rating to Buy with a $392 price target. The consensus target for the HVAC heavyweight is $316.64. The stock was last seen on Monday at $327.82, after rising close to 4% for the day.
Lulu’s Fashion Lounge Holdings Inc. (NASDAQ: LVLU): After the recent initial public offering, this stock has been hit hard, but it got some love as Goldman Sachs started coverage with a Buy rating and a huge $33 price target. Cowen started the shares at Outperform with a $21 target, while Jefferies began its coverage with a Buy rating and a $23 price objective. Monday’s closing print was $11.61, which was up almost 5% for the day.
Merck & Co. Inc. (NYSE: MRK): Guggenheim downgraded the pharmaceutical giant to Neutral from Buy. The shares have traded in a 52-week range of $68.44 to $91.40 and have a $95.74 consensus price objective. The final trade for Monday was reported at $73.42.
Moderna Inc. (NASDAQ: MRNA): Cowen started coverage of the vaccine giant with a Neutral rating. Over the past year, the shares have traded in a wide range of $102.66 to $497.49, and they have a $301 consensus price target. The stock pulled back almost 14% on Monday to close at $265.43.
Nektar Therapeutics Inc. (NASDAQ: NKTR): Goldman Sachs maintained a Neutral rating on the shares and has a $25 price target. The consensus target is slightly higher at $25.86. The final Monday trade was reported at $11.86, which was up close to 10% for the day.
Omnicell Inc. (NASDAQ: OMCL): Wells Fargo resumed coverage with an Overweight rating and a $203 target price. The consensus price objective is $186.33. The final trade on Monday was reported at $180.27.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.